This grant from the National Institute of Diabetes and Digestive and Kidney Diseases aims to support translational and clinical research focused on therapeutic development for chronic forms of minimal change disease, focal segmental glomerulosclerosis, immunoglobulin A nephropathy, and idiopathic membranous nephropathy. Researchers are encouraged to advance the understanding and treatment options for primary glomerular diseases through this opportunity. Closing date for applications is February 27, 2013.
Opportunity ID: 199710
General Information
| Document Type:: | Grants Notice |
| Funding Opportunity Number:: | RFA-DK-12-014 |
| Funding Opportunity Title:: | Advancing Clinical Research in Primary Glomerular Diseases (UM1) |
| Opportunity Category:: | Discretionary |
| Opportunity Category Explanation:: | |
| Funding Instrument Type:: | |
| Category of Funding Activity:: | Food and Nutrition |
| Category Explanation:: | |
| Expected Number of Awards:: | 5 |
| Assistance Listings Number(s):: | 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research |
| Cost Sharing or Matching Requirement:: | No |
| Version:: | Synopsis 1 |
| Posted Date:: | Sep 07, 2012 |
| Last Updated Date:: | |
| Original Closing Date for Applications:: | Feb 27, 2013 |
| Current Closing Date for Applications:: | Feb 27, 2013 |
| Archive Date:: | Mar 30, 2013 |
| Estimated Total Program Funding:: | $ 3,000,000 |
| Award Ceiling:: | $ |
| Award Floor:: | $ |
Eligibility
| Eligible Applicants:: | County governments |
| Additional Information on Eligibility:: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name:: | National Institutes of Health |
| Description:: | The purpose of this Funding Opportunity Announcement (FOA) is to support translational and clinical research that promotes therapeutic development for primary glomerular diseases. The emphasis of this FOA is specifically on chronic forms of minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), immunoglobulin A nephropathy (IGAN), and idiopathic membranous nephropathy (IMN). |
| Link to Additional Information:: | |
| Grantor Contact Information:: | If you have difficulty accessing the full announcement electronically, please contact: |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Synopsis 1 |
Package Status
Package No: 1